Azenosertib
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Azenosertib, covering 2026-03-02 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression [Phase 3]